Feed URL: https://blogs.kent.ac.uk/bio-profiles/2013/08/28/professor-bill-gullick/feed/?withoutcomments=1
Professor Bill Gullick, Ph.D., FRCPath. is Emeritus Professor of Cancer Biology in the School of Biosciences at the University of Kent, U.K. He trained at the University of Leeds and then did postdoctoral research at the Salk Institute in San Diego and then at the Imperial Cancer Research Fund. He worked for eleven years as a Principal Scientist at the ICRF Molecular Oncology Unit at the Hammersmith Hospital and as Professor of Molecular Oncology at the Imperial College School of Medicine before moving to the University of Kent in 2000. Professor Gullick’s research interests include investigations of the role of growth factor receptors in signal transduction, both from the experimental, laboratory perspective but also as a target for the development of new, designed, anti-cancer drugs. His principle area of research was the involvement of the EGF family of ligands and receptors in cancer and their use as prognostic factors and as targets for new treatments. He has been the President of the European CanCer Organisation and the President of the European Association for Cancer Research.
Bill is a member of the Biomolecular Medicine Group
Chairman of the Council of the EACR (2008-2010)
President of the European CanCer Organisation (2001-2003)
President of the European Association for Cancer Research (2004-2006)
Scientific advisor for the Kent Cancer Trust (2004-2012)